LOGO JPG.jpg
Cempra to Report Fourth Quarter and Full Year 2015 Financial Results
February 17, 2016 07:30 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics in the face of rising antibiotic...
LOGO JPG.jpg
The Lancet Infectious Diseases Publishes Positive Phase 3 Study Results for Cempra’s Oral Solithromycin in Community-Acquired Bacterial Pneumonia
February 05, 2016 07:00 ET | Melinta Therapeutics, Inc.
Solithromycin met primary and secondary objectives of non-inferiority compared to moxifloxacin, a potent fluoroquinolone Cempra plans to complete a New Drug Application (NDA) submission to the FDA...
LOGO JPG.jpg
Cempra to Present at the Leerink Partners 5th Annual Global Healthcare Conference
February 03, 2016 07:30 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra and Macrolide Pharmaceuticals Enter Synthetic Manufacturing Process Development Agreement for Solithromycin
February 01, 2016 07:30 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C. and WATERTOWN, Mass., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (NASDAQ:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical...
LOGO JPG.jpg
Cempra to Ring NASDAQ Closing Bell to Mark 10th Anniversary
January 26, 2016 08:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Completes Public Offering of Common Stock
January 12, 2016 16:05 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Prices Public Offering of Common Stock
January 06, 2016 20:42 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra to Present at J.P. Morgan Healthcare Conference
January 06, 2016 07:30 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Announces Proposed Public Offering of $175 Million of Common Stock
January 05, 2016 16:10 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
LOGO JPG.jpg
Cempra Doses Initial Patient in Phase 2 Clinical Trial of Solithromycin in NASH
January 05, 2016 07:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...